Anemia Offers Stronger Protection Than Sickle Cell Trait Against the Erythrocytic Stage of Falciparum Malaria and This Protection Is Reversed by Iron Supplementation. by Goheen, MM et al.
EBioMedicine 14 (2016) 13–14
Contents lists available at ScienceDirect
EBioMedicine
j ourna l homepage: www.eb iomed ic ine.comCommentaryAnemia, Iron Supplementation and Susceptibility to Plasmodium
falciparum MalariaIshag Adam
Faculty of Medicine, University of Khartoum, P.O. Box 102, 11111 Khartoum, SudanDOI of original article: http://dx.doi.org/10.1016/j.ebio
E-mail address: Ishagadam@hotmail.com.
http://dx.doi.org/10.1016/j.ebiom.2016.11.036
2352-3964/© 2016 The Author. Published by Elsevier B.Va r t i c l e i n f oArticle history:
Received 20 November 2016
Accepted 30 November 2016
Available online 1 December 2016
Keywords:
However, a complete understanding of the cellular relationship be-
tween iron andmalaria susceptibility has been lacking, and iron supple-
mentation trials are not possible to conduct without providing
appropriate antimalarial countermeasures which could mask results
and make interpretations difﬁcult. Furthermore, the degree of protec-
tion againstmalaria infection offered by iron deﬁciency is not deﬁnitive-Anemia
Falciparummalaria
Iron supplementation
Sickle cellAnemia and malaria constitute major health problems worldwide,
especially in tropical countries with low resources (WHO, 2008a,
2008b; Black et al., 2003). Although there are several potential causes
of anemia, iron deﬁciency constitutes approximately half of all cases
(WHO, 2008a, 2008b). Other important causal factors include parasitic
infections such as malaria or helminth infections, hemoglobinopathies
and G6PD deﬁciency, traumatic childbirth, as well as other nutritional
deﬁciencies (WHO/UNICEF/UNU, 2001). Most severe malaria infections
are caused by Plasmodium falciparum, and this remains a leading cause
of morbidity and mortality among children in sub-Saharan Africa
(WHO, 2008a, 2008b). Malaria causes anemia primarily through
haemolysis, the destruction of red blood cells (RBCs), although other
factors can be involved, such as long term subclinical malaria infection
inducing anemia of inﬂammation. (Gasim and Adam, 2016). In truth,
the relationship between the host iron status and malaria susceptibility
is quite complicated.
It has been suggested that iron deﬁciency may offer protection
against malaria infection (Gwamaka et al., 2012; Kabyemela et al.,
2008; Jonker et al., 2012). Furthermore, it has been documented that
providing iron supplements to young children living in a malaria en-
demic areawho are iron repletemay increase the risk ofmalaria-related
hospitalization and mortality (Sazawal et al., 2006), among other stud-
ies, suggesting possible increased morbidity following iron supplemen-
tation in malaria endemic areas. Subsequently, the WHO now
recommends that in malaria endemic regions, iron supplements should
only be given where malaria management and preventive measure arem.2016.11.011.
. This is an open access article underavailable (Neuberger et al., 2016; World Health Organization, 2016).
ly understood. Given its prevalence and health consequences, there
remains an important need to address anemia in children in the devel-
oping world – in fact this has become one of WHO Global Targets For
Nutrition 2025. The current policy of the WHO does not reﬂect the dif-
ﬁculties of measuring an individual's iron status in the developing
world, nor does it provide practical, tangible guidelines for what consti-
tutes adequate antimalarial health services or for how long malaria risk
may be elevated following iron administration.
Goheen et al. (2016) have recently assessed the magnitude of pro-
tection from anemia against erythrocytic stage malaria and the safety
of iron supplementation using in vitro assays conducted on RBCs from
children in The Gambia undergoing iron supplementation in a malaria
endemic area where sickle-cell trait is common. They have systemati-
cally characterized P. falciparum growth before, during, and after
12 weeks of iron supplementation. Their method of using in vitro
growth assays provided an optimal procedure to thoroughly examine
the cellular determinants of parasite growth in anemic and iron-supple-
mented children, as they simultaneously tracked measurements of sev-
eral hematological, iron, and inﬂammatory markers over the
supplementation period. Furthermore, this strategy allowed for re-
searchers to eliminate potential confounding factors such asmalaria ex-
posure, antimalarial treatment and prevention services, and variable
follow-up periods. The authors observed that invasion and growth of
various P. falciparum strains were less efﬁcient in RBCs from anemic
children. The authors went on to compare the population level impact
of protection against malaria from anemia versus from sickle-cell trait.
The study reports a greater inﬂuence on population level parasite
growth reduction from anemic RBCs, and an overall prevalence of ane-
mia over four times that of sickle-cell trait. Interestingly, the document-
ed deﬁcits in invasion and growth for erythrocytic stage P. falciparum
were reversed when anemic children received iron supplementation.
It has previously been hypothesised that iron supplementation in-
creases malaria susceptibility by increasing the availability of P.
falciparum's preference for young RBCs (Clark et al., 2014). Goheen et
al. (2016) observed signiﬁcant shifts in RBC populations following ironthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
14 I. Adam / EBioMedicine 14 (2016) 13–14supplementation, ﬁnding younger RBCs are most prevalent at Day 49
post iron supplementation – the exact same period at which parasite
growth increases the most. This ﬁnding supports the hypothesis of in-
creased erythropoietic drive and young RBC population dynamics
inﬂuencing overall malaria susceptibility. Results from this work concur
with WHO recommendations cautioning iron supplementation in ma-
laria endemic areas without extensive health monitoring and antima-
larial preventative services and reveal the need for short-term malaria
prophylaxis during iron supplementation campaigns. Furthermore,
this study provides one possible explanation for why other researchers
may have observed conﬂicting results regarding the malaria-related
risks of iron supplementation, given the transient window of increased
malaria susceptibility the authors observed here. Finally, as the authors
observed a direct correlation between in vitro parasite growth rates and
hemoglobin levels of the RBC donors, this provides a simple and practi-
cal measurement for healthcare workers to take into consideration re-
garding evaluation of malaria susceptibility and iron supplementation,
as opposed to more laborious, less straightforward, and often unavail-
able measurements of iron status using other iron related biomarkers.
Given the degree of protection afforded by anemia against malaria
invasion and growth, the widespread prevalence of anemia in malaria
endemic areas, and the well-known observation that people of African
descent have lower normal hemoglobin andMCV values, as the authors
put forth, it is worth questioning whether these altered hematological
values amongAfricans have a stronger genetic basis than previously ap-
preciated (as opposed to being solely environmentally related). Thus,
much like the other hemoglobinopathic signatures, could anemia be
an adaptation to live under signiﬁcant malaria pressure?
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